Morgan, Adam
Morgan, Adam was paid $23K by Medicaid between May 2020 and May 2023, across 17 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 29% of everything it billed.
33Billing provider infoMORGAN, ADAM
MADISON, WI 53715
MADISON, WI 53715
33aNPI1780849604assigned 07/21/2008
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$23K
24GClaims4,166
24DCodes billed17
24AFirst – last monthMay 2020 – May 2023
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Wisconsin
Rank by total paid#13 of 72
Median peer was paid$1K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 516 | $4K | |
| 2021 | 1,470 | $8K | |
| 2022 | 1,692 | $10K | |
| 2023 | 488 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29% | 333 | 312 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21% | 1,316 | 1,009 | $5K |
| 80053 | Comprehensive metabolic panel | 20% | 1,239 | 843 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 63 | 63 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.9% | 29 | 29 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.6% | 37 | 24 | $824.20 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.5% | 13 | 13 | $570.52 |
| 81025 | 2.0% | 128 | 118 | $449.17 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 285 | 149 | $396.48 |
| 81001 | 1.1% | 180 | 161 | $250.06 | |
| 84484 | <1% | 83 | 58 | $124.56 | |
| 83605 | <1% | 70 | 40 | $105.07 |
5 more codes
| 83690 | <1% | 112 | $67.83 | |
| 80306 | <1% | 13 | $59.43 | |
| 82077 | 0% | 131 | $0.00 | |
| 83735 | 0% | 92 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.